240 related articles for article (PubMed ID: 28179255)
1. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
Montanari A; Lazzeroni D; Pelà G; Crocamo A; Lytvyn Y; Musiari L; Cabassi A; Cherney DZI
Am J Physiol Renal Physiol; 2017 May; 312(5):F870-F878. PubMed ID: 28179255
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
van der Linde NA; van den Meiracker AH; Boomsma F
J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
[TBL] [Abstract][Full Text] [Related]
4. Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.
Shahid M; Francis J; Matrougui K; Majid DS
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F217-24. PubMed ID: 20410217
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans.
Perinotto P; Biggi A; Carra N; Orrico A; Valmadre G; Dall'aglio P; Novarini A; Montanari A
J Am Soc Nephrol; 2001 Aug; 12(8):1706-1712. PubMed ID: 11461943
[TBL] [Abstract][Full Text] [Related]
6. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
[TBL] [Abstract][Full Text] [Related]
7. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
[TBL] [Abstract][Full Text] [Related]
8. Neuronal nitric oxide synthase, nNOS, regulates renal hemodynamics in the postnatal developing piglet.
Rodebaugh J; Sekulic M; Davies W; Montgomery S; Khraibi A; Solhaug MJ; Ratliff BB
Pediatr Res; 2012 Feb; 71(2):144-9. PubMed ID: 22258124
[TBL] [Abstract][Full Text] [Related]
9. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
Broere A; Van Den Meiracker AH; Boomsma F; Derkx FH; Veld AJ; Schalekamp MA
Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
[TBL] [Abstract][Full Text] [Related]
11. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
12. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
Lahera V; Navarro J; Biondi ML; Ruilope LM; Romero JC
Am J Physiol; 1993 Feb; 264(2 Pt 2):F344-7. PubMed ID: 8383451
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans.
Montanari A; Biggi A; Carra N; Fasoli E; Calzolari M; Corsini F; Perinotto P; Novarini A
Hypertension; 2000 Jan; 35(1 Pt 2):518-23. PubMed ID: 10642352
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
van der Linde NA; Boomsma F; van den Meiracker AH
J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
17. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A
J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
[TBL] [Abstract][Full Text] [Related]
18. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs.
Salom MG; Lahera V; Miranda-Guardiola F; Romero JC
Am J Physiol; 1992 May; 262(5 Pt 2):F718-22. PubMed ID: 1590415
[TBL] [Abstract][Full Text] [Related]
19. Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension.
Krier JD; Romero JC
Am J Physiol; 1998 Jan; 274(1):R175-80. PubMed ID: 9458915
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
